Status: current, Defined. Date: 31-Aug 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4448221000168117 | Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 9 mg / 5 mL + lidocaine hydrochloride monohydrate 212 mg / 5 mL + tetracaine hydrochloride 25 mg / 5 mL) solution, 5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4448231000168119 | Laceraine Topical Wound Anaesthetic solution, 5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | Is a | Laceraine Topical Wound Anaesthetic | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | Is a | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has manufactured dose form | solution | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has Australian BoSS | adrenaline (epinephrine) acid tartrate | true | Inferred relationship | Some | 163796270 | |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has intended active ingredient | adrenaline (epinephrine) | true | Inferred relationship | Some | 163796270 | |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has Australian BoSS | lidocaine hydrochloride monohydrate | true | Inferred relationship | Some | 1837862528 | |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 1837862528 | |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has unit of use | vial | true | Inferred relationship | Some | 13812938 | |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has Australian BoSS | tetracaine hydrochloride (AU substance) | true | Inferred relationship | Some | 1273692072 | |
| Laceraine Topical Wound Anaesthetic solution, 5 mL vial | has intended active ingredient | tetracaine (amethocaine) | true | Inferred relationship | Some | 1273692072 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Laceraine Topical Wound Anaesthetic solution, 5 x 5 mL vials | has TPUU | True | Laceraine Topical Wound Anaesthetic solution, 5 mL vial | Inferred relationship | Some | 1622807207 |
| Laceraine Topical Wound Anaesthetic solution, 5 x 5 mL vials | has TPUU | True | Laceraine Topical Wound Anaesthetic solution, 5 mL vial | Inferred relationship | Some | 1117695971 |
Reference Sets
Trade product unit of use reference set
FHIR